CARE vs HBAN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Feb 03, 2026

CARE

64.1
AI Score
VS
CARE Wins

HBAN

59.0
AI Score

Investment Advisor Scores

CARE

64score
Recommendation
BUY

HBAN

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CARE HBAN Winner
Forward P/E 13.6612 10.6496 HBAN
PEG Ratio 0 1.9364 Tie
Revenue Growth 6.4% 11.1% HBAN
Earnings Growth 5.9% -11.7% CARE
Tradestie Score 64.1/100 59.0/100 CARE
Profit Margin 20.0% 28.7% HBAN
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD CARE

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.